Dr Reddy's gets seven observations from USFDA for Andhra plant

Dr Reddy's Laboratories faces scrutiny. The USFDA issued a Form 483 after inspecting their Srikakulam facility. The inspection, which occurred in July 2025, revealed seven observations. These observations relate to potential violations of the Food, Drug and Cosmetic Act. Dr Reddy's plans to address these concerns promptly. The company aims to resolve the issues within the given timeframe.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5DHes8o
via IFTTT